![](https://www.pdfsearch.io/img/d024aea164d198460a43aba37f726661.jpg) Date: 2017-06-02 05:25:57
| | Final Results of a Phase II Multicenter Trial of HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab Combination Treatment in Patients with Stage IIIB-IV Unresectable or Metastatic Melanoma Abstract #1664Add to Reading ListSource URL: www.takara-bio.co.jpDownload Document from Source Website File Size: 478,76 KBShare Document on Facebook
|